CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: ANALYSIS OF RESPONSE AND PROGRESSION-FREE SURVIVAL HAZARD RATIO OVER TIME

被引：0

作者：

Dimopoulos, M. A. ^{[1
]}

Stewart, A. K. ^{[2
]}

Wang, M. ^{[3
]}

Maisnar, V. ^{[4
,5
]}

Minarik, J. ^{[6
]}

Bensinger, W. I. ^{[7
]}

Mateos, M. V. ^{[8
]}

Ben-Yehuda, D. ^{[9
]}

Kukreti, V. ^{[10
]}

Obreja, M. ^{[11
]}

Aggarwal, S. ^{[11
]}

Moreau, P. ^{[12
]}

Palumbo, A. ^{[13
]}

机构：

[1] Univ Athens, Sch Med, Athens, Greece

[2] Mayo Clin, Scottsdale, AZ USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Charles Univ Prague, Fac Hosp, Hradec Kralove, Czech Republic

[5] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic

[6] Univ Hosp Olomouc, Olomouc, Czech Republic

[7] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[8] Univ Hosp Salamanca IBSAL, Salamanca, Spain

[9] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel

[10] Princess Margaret Canc Ctr, Toronto, ON, Canada

[11] Amgen Inc, San Francisco, CA USA

[12] Univ Nantes, Nantes, France

[13] Univ Turin, Turin, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：83 / 83

页数：1